pharma · Chronic kidney disease · Advanced solid tumors
Bayer
Bayer AG
Bayer clinical programs — 13 development programs from ClinicalTrials.gov with phase, modality, indication, and trial identifiers.
Company details
- Status
- Public
- HQ
- Kaiser-Wilhelm-Allee, Leverkusen, North Rhine-Westphalia 51373, DE
- Employees
- 97,894
- Programs
- 47
- Drugs
- 62
- Patents
- 5
Bayer projects
13 ClinicalTrials.gov programs sponsored by Bayer.
Bayer has 13 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.
Clinical programs
-
12916
Bayer AG
"Patients with interstitial lung disease associated pulmonary hypertension"
1 trial -
14308
Bayer AG
Patients symptomatic with pulmonary hypertension associated with left ventricular systolic dysfunction (PH-sLVD)
1 trial -
20289
Bayer AG
Solid tumors harboring NTRK fusion
1 trial -
20290
Bayer AG
Solid tumors harboring NTRK fusion
1 trial -
21839
Bayer AG
Chronic kidney disease in type 2 diabetes mellitus
1 trial -
22040
Bayer AG
Chronic kidney disease
1 trial -
22752
Bayer AG
HER2 mutation, Advanced solid tumors
1 trial -
BAY 1021189
Bayer AG
Chronic heart failure with reduced ejection fraction
1 trial -
BAY 2599023
Bayer AG
Hemophilia A
1 trial -
BAY 3713372 Bayer for MTAP-deleted Solid Tumors
Bayer AG
MTAP-deleted Solid Tumors
1 trial -
BAY 73-4506, BAY 734506
Bayer AG
Solid malignant tumors
1 trial -
Placebo to BAY 3401016, BAY 3401016
Bayer AG
Alport Syndrome, Chronic kidney disease
1 trial -
placebo of BAY 3427080, BAY 3427080
Bayer AG
Sleep disturbances associated with menopause
1 trial
Frequently asked questions
How many clinical projects does Bayer have?
13 published programs are linked to this sponsor in our ClinicalTrials.gov index.
Is this the complete company pipeline?
This directory lists published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.